{"id":"abx464-single-dose","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL2074774","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"featherless-qwen","explanation":"ABX464 targets a novel mechanism involving the modulation of RNA splicing, which is essential for the production of viral proteins in HIV-infected cells, thereby reducing viral load.","oneSentence":"ABX464 is a small molecule that modulates the RNA splicing process to inhibit HIV replication.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T04:32:38.658Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"HIV infection"}]},"trialDetails":[{"nctId":"NCT02792686","phase":"PHASE1","title":"ABX464 First in Man Study","status":"COMPLETED","sponsor":"Abivax S.A.","startDate":"2014-03","conditions":"Healthy Volunteers","enrollment":24},{"nctId":"NCT05032560","phase":"PHASE1","title":"Safety and Pharmacokinetics Study in Healthy Japanese Volunteers","status":"COMPLETED","sponsor":"Abivax S.A.","startDate":"2021-09-27","conditions":"Healthy Volunteers","enrollment":48},{"nctId":"NCT05121714","phase":"PHASE1","title":"Evaluation of the Potential CYP1A2-mediated Drug Drug Interaction Safety, and Tolerability of ABX464","status":"COMPLETED","sponsor":"Abivax S.A.","startDate":"2020-12-17","conditions":"Healthy","enrollment":59},{"nctId":"NCT02731885","phase":"PHASE1","title":"Food Effect on Pharmacokinetic Parameters of ABX464","status":"COMPLETED","sponsor":"Abivax S.A.","startDate":"2014-09","conditions":"Healthy Volunteers","enrollment":48}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"ABX464 Single dose","genericName":"ABX464 Single dose","companyName":"Abivax S.A.","companyId":"abivax-s-a","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ABX464 is a small molecule that modulates the RNA splicing process to inhibit HIV replication. Used for HIV infection.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}